Athens, OH, United States of America

Reetobrata Basu

This inventor holds 8 USPTO granted patents and 4 published patent applications. Top assignees: Ohio University, Other. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reetobrata Basu. Retrieved from https://idiyas.com/inventor/reetobrata-basu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:

goldMedal6 out of 239 
 
Ohio University
 patents
silverMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2022-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Reetobrata Basu: Innovator in Cancer Treatment

Introduction

Reetobrata Basu is a prominent inventor based in Athens, Ohio, known for his significant contributions to cancer treatment research. With a total of eight patents to his name, he has made remarkable strides in the field of medical science.

Latest Patents

Among his latest patents are innovative methods for treating cancers using fat specific protein 27 (FSP27) compositions. These patents describe FSP27 compositions and methods that aim to provide new avenues for cancer treatment, showcasing his dedication to advancing medical technology.

Career Highlights

Reetobrata Basu has had a notable career, primarily associated with Ohio University. His work has focused on developing therapeutic strategies that leverage the unique properties of FSP27, contributing to the ongoing fight against cancer.

Collaborations

Throughout his career, Basu has collaborated with esteemed colleagues, including John J. Kopchick and Vishwajeet Puri. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Reetobrata Basu's work exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. His patents and collaborations reflect a commitment to improving patient outcomes through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…